For tumor-infiltrating lymphocyte quantification in melanoma, an AI algorithm demonstrates superior reproducibility and prognostic associations.

Dr. Nicholas James shares why it’s important to identify which patients with high-risk, non-metastatic prostate cancer will ...

An AI-based EGFR biomarker tool could preclude the need for a rapid PCR test in nearly half of advanced lung adenocarcinoma cases, a study has suggested.